Micro-Sphere increases capsule filling capacity

8 Oct 2018

The MG2 Tekna increases the CDMO’s manufacturing capacity to up to 500 million capsules per year.

Switzerland-based CDMO Micro-Sphere has announced that its MG2 Tekna capsule filling machine is now online, adding further strength to its offering in encapsulation for inhalation products.

Micro-Sphere increases capsule filling capacity

Situated in a dedicated cleanroom at Micro-Sphere’s recently expanded facility near Lugano in Ticino, the MG2 Tekna is in an area of controlled relative humidity of 20% (rH 20% +/- 5%), has a production capability of 110,000 cps/hour and increases the CDMO’s manufacturing capacity to up to 500 million capsules per year.

Alongside the MG2 Tekna machine the company has also invested in a MultiNETT, a net weight control system that monitors and reports the net weight of each dosed capsule. The MultiNETT system employs capacitive tomography to guarantee accuracy and precision and rejects all capsules it deems out of specification.

Michael Grassberger has recently been promoted to managing director at Micro-Sphere and is spearheading the company’s plans to increase its client portfolio with its greater capacity and improved services.

He said: “Micro-Sphere has always strived to offer the best possible service to our customers. This investment is the result of increasing client demand for encapsulation services and our drive to offer customers real commercial benefits.

“This new machinery will offer high-quality products, reduced production times, detailed batch reporting and, ultimately, cost savings.

“Added to our existing Harro Höfliger drum dosing equipment the new MG2 Tekna dosator system means we are the only CDMO in the world to offer these two important commercial size filling techniques under one roof.”

This latest announcement is the final step in Micro-Sphere’s 21 million CHF (€19 million) investment plan to expand its GMP manufacturing capabilities and comes as the company celebrates its 20th year in business.

Michael added: “In all of its 20 years our company has been committed to strengthening our niche capabilities in spray drying and inhalables. The expansion has seen a significant investment of time and resource and now enables us to move forward with our planned growth and hopefully garner success for at least another 20 years.”

Read More

Related news

New HCP Kit for automated impurity analysis of biotherapeutics

New HCP Kit for automated impurity analysis of biotherapeutics

21 Jun 2019

Ready-to-use immunoassay kit increases analytical output and productivity in bioprocess workflows.

Read more 
Sanofi and Google to develop new healthcare Innovation Lab

Sanofi and Google to develop new healthcare Innovation Lab

20 Jun 2019

Collaboration aims to change how Sanofi develops new treatments and will focus on to better understand patients and diseases, to increase Sanofi’s operational efficiency, and to improve the experience of Sanofi’s patients and customers.

Read more 
Catalent to purchase BMS manufacturing facility

Catalent to purchase BMS manufacturing facility

19 Jun 2019

Customers to have access to state-of-the-art sterile biologics fill/finish and oral solids manufacturing and packaging platforms.

Read more 
Inaugural Bio Integrates conference highlights industry's inefficiency in developing products

Inaugural Bio Integrates conference highlights industry's inefficiency in developing products

18 Jun 2019

Industry leaders give voice to issues and trends shaping the biotech sector, including the importance of collaboration.

Read more 
Colorcon launches Opadry Enteric for use with hydro-alcoholic media

Colorcon launches Opadry Enteric for use with hydro-alcoholic media

17 Jun 2019

A fully formulated one-step system providing simple preparation and ease-of-use for film coating.

Read more 
SenzaGen granted its first patent for GARD potency biomarker test

SenzaGen granted its first patent for GARD potency biomarker test

16 Jun 2019

Company can now offer an animal-free test method to quantify the strength of an allergenic effect.

Read more 
Affordable measles and rubella vaccines using NevoLine manufacturing platform

Affordable measles and rubella vaccines using NevoLine manufacturing platform

14 Jun 2019

Univercells' propriety bioproduction platform has already proven success.

Read more 
Leaf Expression Systems launches first line of Hypertrans research products

Leaf Expression Systems launches first line of Hypertrans research products

13 Jun 2019

Plant-expression deal for difficult to produce proteins, vaccines, metabolites and natural proteins.

Read more 
Clinical supply milestone reached for triple-negative breast cancer treatment

Clinical supply milestone reached for triple-negative breast cancer treatment

12 Jun 2019

PhoenixMD and WuXi STA have produced a multikilogram drug supply for PMD-026 under GMP manufacturing practices.

Read more 
Combining IT and OT software to solve manufacturing’s most frequent challenges

Combining IT and OT software to solve manufacturing’s most frequent challenges

11 Jun 2019

PTC and Rockwell Automation combine technologies to accelerate customers’ digital transformation initiatives.

Read more